Načítá se...
Risk factors for an atherothrombotic event in patients with diabetic macular edema treated with intravitreal injections of bevacizumab
AIM: To identify risk factors for an atherothrombotic event (ATE) among patients who were treated for diabetic macular edema (DME) with intravitreal bevacizumab injections. METHODS: This retrospective study enrolled all consecutive patients with DME who were treated by intravitreal bevacizumab from...
Uloženo v:
| Vydáno v: | Int J Ophthalmol |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
International Journal of Ophthalmology Press
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7459222/ https://ncbi.nlm.nih.gov/pubmed/32953580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18240/ijo.2020.09.12 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|